KTTA

Pasithea Therapeutics Corp (KTTA)

US
$ 1.91-10.75%

Price Chart

Key Statistics

Market Cap
$ 2.55M
P/E Ratio
0.00
Revenue (TTM)
$ 486.56K
Volume
447.03K
52W High
$ 7.50
52W Low
$ 0.80
Dividend Yield
0.00%
Beta
0.54

Technicals

50-Day MA
1.2697
200-Day MA
2.9075
52 Week High
7.5
52 Week Low
0.797

About KTTA

Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and canc.

Employees
4
Headquarters
Miami Beach, FL
CEO
Dr. Lawrence Steinman BA, M.D., Ph.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
SYTA
Siyata Mobile Inc. ...
$ 2.16
63.63
CAPS
Capstone Holding Co...
$ 2.53
52.41
AMST
Amesite Inc. Common...
$ 3.33
48.66
SPCE
Virgin Galactic Hol...
$ 4.73
41.20
KTTA
Pasithea Therapeuti...
$ 1.06
23.17

Top Losers

Symbol/Name
LTP
% Chg
CLIK
Click Holdings Limi...
$ 0.47
-34.07
CGBS
Crown LNG Holdings ...
$ 0.07
-23.52
IXHL
Incannex Healthcare...
$ 0.23
-22.33
AYTU
Aytu BioPharma Inc....
$ 2.09
-19.30
ASST
Asset Entities Inc....
$ 6.00
-12.66